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Continuous Flow and the Prothrombinase-Catalyzed
Activation of Prothrombin
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Summary
The activation of prothrombin by prothrombinase was investi-
gated in a continuous flow system at 25 "C. A glass capillary,
containing a continuous phospholipid bilayer attached to the
interior surface, was first perfused with factor Va. The factor Va
bound to the phospholipid surface functioned as sites for the
formation of prothrombinase, when subsequently a factor Xa and
prothrombin containing solution was perfused. Under the condi-
tions used, steady-state rates of prothrombin activation were
attained after 4 to 15 min. The rates of prothrombinase formation
increased with increasing factor Xa concentrations and flow rates,
which is compatible with the assembly of prothrombinase being
dependent on the flux of factor Xa to the phospholipid-bound
factor Va. As long as factor Xa and prothrombin weie present in
the fluid phase the assembly of prothrombinase was apparently
irreversible; during at least20 min no loss of activity occurred.
The steady-state rate of prothrombin activation was dependent on
the surface concentration of prothrombinase, at 1.0 pM pro-
thrombin and a shear rate of 82 s-1 the average rate was 870 mol
thrombin/min per mol prothrombinase. In contrast to test tube
experiments it was observed that in this flow system, the
formation of s-thrombin is favoured above the formation of
meizothrombin (des fragment L).
Introduction
In vivo blood coagulation is a complex process, which requires
actions of and interactions between the vascular wall, blood
platelets and the coagulation system. Of the coagulation system
many reactions are membrane bound processes, i.e. they take
place on either the platelet or endothelial cell membrane.
Consequently, during coagulation reactants must be transported
from the blood stream to the membrane surface. These transport
processes, and therefore the formation and activities of the
membrane-bound enzymatic complexes, are dependent on the
local flow conditions (1, 2).
Recently it has been pointed out by Gemmell et al. (3) that the
progress of coagulation reactions during flow cannot be extrapo-
lated from static, closed systems. They reported on the activation
of factor X by membrane-bound tissue factor and factor VII(a),
during flow, and found that the steady-state catalytic activity of
the enzymatic complex is independent of the concentration of
factor VII(a) in the fluid phase. In addition it was shown, that the
factor \fII(a) concentration in the perfused solution determined
the time required to achieve the steady-state.
Abbreviations:
AIIII, antithrombin III; p-NPGB, p-nitrophenyl p'-guanidinobenzo-
ate hydrochloride; HSA, human serum albumin; 52238, D-phenylalanyl-
L-pipecolyl-L-arginine-p-nitroanilide dihydrochloride.
Correspondence to: Dr. Th. Lindhout, Department of Biochemistry,
University of Limburg, P.O. Box 616, 6200 MD Maastricht, The
Netherlands
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In the past, detailed studies have been published on the
kinetics and mechanisms of prothrombin activation (see refs.4
and 5, and references therein), however, they were all performed
in systems where the dynamic aspects of flow could not be
examined. Prothrombinase, a key enzymatic complex in blood
coagulation, is a dissociable Caz+-dependent enzymatic complex,
composed of the enzyme factor Xa, the non-enzymatic eofactor
factor Va, and a suitable phospholipid surface. This complex is a
highly efficient activator of prothrombin, which leads to the
formation of thrombin. In this paper, we describe the activation
of prothrombin by prothrombinase under well-defined flow
conditions, obtained by perfusion of reactants through a phos-
pholipid coated glass capillary.
Materials and Methods
Capillaries
Glass capillaries with an internal diameter of 0.58 mm and a length of
72.7 cm, were obtained from Brand, FRG. They were boiled for 30 min in
2mglml Sparkleen (Fisher Scientific Co., Pittsburgh, USA). After
extensive washing with deionized water the capillaries were placed
overnight in a30"/" chromic acid solution. The capillaries were then again
extensively washed and kept in 50% ethanol. Capillaries were used the
same day; prior to use they were dried.
Proteins and Phospholipid Vesicles
Bovine factor V and factor Va (6) and bovine prothromtrin (7) were
prepared and quantified as described. Bovine antithrombin III (ATIID
was isolated as reported previously (8). Human prothrombin was purified
as described (9),'and the molar concentration was determined, after
complete activation with Echb carinatus venom (Sigma), by active site
titration with p-NPGB (10). Human factor Xa was prepared by activation
of purified factor X (11) with the factor X activating protein from
Russell's Viper venom (KabiVitrum, Stockholm, Sweden) and isolated as
described for the bovine protein (12). The molar concentration was
determined by active site titration with p-NPGB (13).
Meizothrombin (des fragment 1) was prepared as follows. Human
prothrombin (16 pM) was activated by Echis carinatus venom (0.5 mg/ml)
in 50 mM Tiis-HCl (pH 7.5) containing 100 mM NaCI, 10 mM CaC12, and
10 mM benzamidine-HCl. After 5 min the conversion of prothrombin was
terminated by the addition of EDTA to a final concentration of 20 mM,
and the mixture was applied to a column (1.5 x 30 cm) of eAE-
Sepharose (Pharmacia) equilibrated in 50 mM Tiis-HCl (pH 7.5),
100mM NaCl, and 10mM benzamidine-HCl at 4"C. A linear salt
gradient, from 0.10 to 0,60 M NaCl in 50 mM This-HCl (pH 7.5), 10 mM
benzamidine-HCl (2 x 150 ml), was applied and meizothrombin (des
fragment 1), assessed by its activity on 52238, eluted at about 0 25 M
NaCl. The fractions with the highest activity were pooled. In these steps,
the presence of 10 mM benzamidine-HCl was an absolute requirement;
upon its omission the only product was o-thrombin. For further use, the
benzamidine was rapidly removed by gel filtration. The preparation was
applied to a column (1.6 x 60 cm) of Sephadex G50 (Pharmacia) in
50 mM Tiis-HCl (pH 7.9), L75 mM NaCl at 4'C. Fractions were immedi-
ately pooled and stored at -70'C. The final preparation was over 95%
pure as judged by SDS polyacrylamide gelelectrophoresis (14), and the
concentration of meizothrombin (des fragment 1) was assessed by active
site titration with p-NPGB (10).
Small unilaminar vesicles, composed of 75o/" egg phosphatidylcholine
and257" brain phosphatidylserine were prepared by sonication in 50 mM
Tiis-HCl (pH 7.5) containing 100 mM NaCl (7) To determine amounts of
phospholipid covering the inner wall of the capillaries, also vesicles were
prepired with tracer concentrations of dioleoylphosphatidyl-(1aC)serine
(specific actiyity 2.0 GBq/mmol; Amersham, UK). The vesicle suspension
had a specific activity of 97.8 MBq/mmol. Radioactivity measurements
were performed with a Beckrnan LS3801 scintillation counter, utilizing a
liquid scintillation cocktail (Formula-989, Biotechnology systems, Boston,
usA).
The Activation of Prothrombin by Surface-Bound Prothrombinase
Capillaries were coated with phospholipid, by 20 min incubation with a
1 mM vesicle suspension, and then rinsed with Tiis-buffer (50 mM Tris-
HCI [pH 7.9] containing 175 mM NaCl, 3.0 mM CaCl2, and 0.5 mg
ovalbumin/ml) at a flow rate of L.2 ml/min (wall shear rate 1,044 s-') for
2 min. The capillaries were then perfused with factor Va, diluted in the
Tiis-buffer, for 10 min at a flow rate of 30 pVmin (wall shear rate 26 s-r|.
Immediately hereafter the capillaries were washed with Tiis-buffer at a
flow rate of 30 pl/min during 10 min, and then perfused with a solution of
factor Xa and prothrombin in the same Tiis-buffer. Drops were collected
at the outlet and 20 pl aliquots were immediately diluted in 430 pl of
50mM Ti is-HCl (pH7.9),  I75 mM NaCl,20mM EDTA, contain ing
0.5 mg HSA/ml and assayed for thrombin by the addition of 50 pl
chromogenic substrate (52238, Kabivitrum, Stockholm, Sweden). The
final concentration 52238 was 0.22 mM and the rate of absorbance
increase was recorded at 405 nm on a dual wavelength spectrophotometer
(ieference wavelength: 500 nm) at 37 "C The amounts of thrombin
formed were calculated from a standard curve constructed with purified
human s-thrombin (15) under identical conditions.
A11 perfusions were performed by the use of a syringe pump (Harvard
Apparatus Co., Massachusetts, USA) resulting in a continuous laminar
flow through the capillaries. The experiments were performed in a
climated room at 25 + 7'C, and the conditions mentioned were routinely
applied, unless otherwise indicated.
Detemination of Factor Va Bound to the Phospholipid Coated Capillaries
At the end of each experiment the capillaries were emptied and
subsequently washed with one capillary volume of 0.2Yo Tiiton X100 in
50 mM Tris-HCl (pH 7.9), 175 mM NaCl, 3.0 mM CaCl2. The solutions
were mixed and a sample was diluted 10-fo1d with Ttis-buffer, and assayed
for factor Va.
Factor Ua Assay
Factor Va samples (10 pl) were added to cuvettes, containing a
solution of factor Xa, phospholipid vesicles and CaCl2 in 50 mM Tiis-HCl
(pH 7.9), 175 mM NaCl, and 0.5 mg HSA/m1. After 2 min at 37 'C, 10 pl
bovine prothrombin was added. The final concentrations were 0.10 nM
factor Xa, 10 pM phospholipid, 10 mM CaCl2, and 0.2 pM prothrombin
in a final volume of 125 pl. After 5 min the conversion of prothrombin
was terminated by the addition of 325 1tl of 50 mM Tiis-HCl (pH 7.9),
175 mM NaCl, 20 mM EDTA, and 0.5 mg HSA/ml. Hereafter, 50 pl
2.2 mM 52238 was added and the amount of thrombin formed was
determined. The amounts of thrombin formed were linearly dependent on
the amounts of factor Va present, up to at least 2.0 pM factor Va in the
assay.
In samples derived from the capillaries, 0.01% Tiiton X100 was
present. Because the assay was sensitive to such an amount of
Tiiton X100, factor Va reference curves were constructed in the presence
of the same detergent concentration Each factor Va determination was
performed in duplicate, and the differences between the individual values
of each duplicate varied between zero and approximately 10% of the
mean values.
Measurement of Meizothrombin (Des Fragment 1)
Samples (20 pl) from drops collected at the capillary outlet, were
immediately diluted in cuvettes, containing 430 pl of 50 mM Tiis-HCl
(pH 7.9), 175 mM NaCl, 20 mM EDTA, 0.5 mg HSA/ml, 4 nM ATIII,
and 2 pg unfractionated heparin/ml (165 USP U/mg) at 37 'C. After
L min 50 u12.2 mM 52238 was added and the residual amidolytic activity
was determined. From previous work it follows that under these condi-
tions o-thrombin activity will be completely neutralized, whereas this is
not the case for meizothrombin (des fragment 1) activity (8). The amounts
of meizothrombin (des fragment 1) present in the samples were calculated
from the residual amidolytic activities utilizing a standard curve con-
structed with purified meizothrombin (des fragment 1)
Theory of Protein Adsorption to the Interior Surface of a Capillary
During laminar flow along the inner wall of a capillary, in which a fluid
phase protein binds to the capillary wall, the transfer of the protein occurs
in a thin diffusion layer between the bulk solution and the surface. It has
been derived (16) that, provided the binding capacity of the surface is
sufficiently large as compared to the protein content of the boundary
layer, and if the binding sites are uniformly distributed, the rate of protein
flow (v5, mol cm-2 s 1) towards the surface is given by:
vs : 0.54 (yD2lx)1/3 Su G)
where y is the shear rate (s-1). D is the diffusion coefficient of the protein
(cm2ls), x is the distance from the capillary entrance (cm), and 56 is the
concentrhtion of protein in the fluid phase (mol/ml). The shear rate is
given by:
y :32Qt(nd3) ( ID
where Q is the flow rate (ml/s), and d is the internal diameter (cm) of the
capillary.
Results
Determination of the Amounts of Phospholipid Bound to the
Interior Surfaces of Capillaries
It has been demonstrated that; when glass coverslips are placed
in a vesicle suspension, the coverslip surface becomes covered
with a continuous, planar membrane (17). This technique has
been used for the binding of phospholipids to glass capillaries (3).
We used virtually the same technique, and in order to verify the
formation of a phospholipid bilayer we determined the amounts
of phosphotpid bound, by use of vesicles containing toc-labelled
phosphatidylserine. Clean and dry capillaries were filled with a
suspension of the small unilaminar phospholipid vesicles, as
outlined in "Mate-rials and Methods". Non-bound phospholipid
was removed by perfusion of Tfis-buffer at a flow rate of I.2 nll
min for 2 min. The capillaries were emptied, washed with
approximately 0.5 ml of scintillant and broken into 3 segments.
All was collected in a vial containing scintillant to a final volume
of 5 ml and the radioactivity was measured.
Our results showed that 6.5 x 10-10 mol phospholipid was
bound per cm2 (n : 8; SD : 0.6 x 10-10 mol/cm2). Such an
amount of phospholipid agrees reasonably well with published
data (ref.3, and references therein). In addition, we demon-
strated the bilayer to be stable. After the removing of non-bound
phospholipid, capillaries were perfused for 10 min with 0.15 nM
factor Va followed by a 30 min perfusion with Tiis-buffer al a rate
of 30 pl/min. The amount of radioactivity retained in the capil-
laries, assessed as described above, corresponded with 5.9 x
10-10 moVcm2 (n: 4; SD : 0.9 x 10-10 mol/cm2) phospholipid
bound to the capillary surfaces.
We also established, with the use of the 1ac-labelled vesicles,
that the procedure for the determination of the amounts of
factor Va bound to the phospholipid surfaces, removed essen-
tially all bound phospholipid. Again capillaries were filled with
the vesicle suspension, and washed as described. Then each
capillary was emptied in a vial containing 5 ml of scintillant and
washed with one volume of the Tiis-buffered Tiiton X100 solu-
tion. By this procedure we recovered an amount of radioactivity
correspondinf to e .Z x 10-10 mol phospholipid/cm2 (n : 4; SD :
0.1 x 10 10 mol/cm2).
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Fig ) The rate of thrombin formation as function of time. Prothrombin
(1.0 pM) and factor Xa (0.50 nM) were perfused through a p-hospholipid
coated capillary in thc presence of 2.4 fmol factor Va/cmr (O), or a
capillary which was not coated with phospholipid (A). See thc tcxt for
further experimental details
Binding of Factor Va to Phospholipid-Coated Capillaries
In order to obtain surface-bound prothrombinase we first
adsorbed factor Va to phospholipid coated capillaries. To this
end, a phospholipid-coated capillary was pefused with 0.15 nM
factorVa for 10min (30pVmin; wall  shear rate 26sr.1 and
subsequently washed for 10 min with buffer (30 pl/min). The
amount of factor Va bound to the phospholipid-coated capillary,
determined as outlined in "Materials and Methods". was
2.4 fmollcmz. Given the interior surface of the capillary
(2.31 cmz) and the factor Va influx (300 pl of 0.15 nM) it can be
calculated that 12"/o of the amount of factor Va perfused became
bound. We investigated the distribution of the factor Va bound to
the phospholipid surface, by breaking a capillary, perfused with
factor Va and washed with buffer, into two pieces of approxi-
mately equal length. An amount of 2.6 fmol factor Va was bound
in the inlet part (l : 6.4 cm) and2J. fmol in the outlet part of the
capil lary 0 : 6.3 cm); hence the rat io of the amounts is 1:0.81.
The Course oJ Thrombin Generation by Surface-Bound
Prothrombinase
Fig. 1 shows thrombin generation obtained by the perfusion of
0.50 nM factor Xa and 1.0 prM prothrombin at a flow rate of
94 pllmin (wall shear rcte 82 s-'), after a phospholipid-coated
capillary had been perfused with a solution of 0.15 nM factor Va
for 10 min. It is seen that under these conditions thrombin is
measurable at the outlet after about L min. Then the rate of
thrombin formation rapidly increases until a steady-state rate of
approximately 5.5 pmol/min is obtained, which takes about
4 min. The steady-state thrombin formation is stable for at least
20 min, which could suggest that during the course of the
perfusion with factor Xa and prothrombin no significant amount
of factor Va is eluted from the phospholipid coated capillary. In
order to verify this we determined the amount of bound fac-
tor Va, at the end of the pe-rfusion with factor Xa and prothrom-
bin, and found 2.5 fmoUcm'. An amount which is identical to the
amount of factor Va bound at the onset of the perfusion with
factor Xa and prothrombin, as determined in the previous
sect10n.
The observed thrombin formation is truly the consequence of
prothrombinase-catalyzed activation of prothrombin because in
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Fig 2 The steady-state thrombin fbrmation as function of thc amount of
bound factor Va. Phospholipid-coated capillaries were perfused with
factor Va solutions of variable concentration Steady-state rates of
thrombin formation were determincd at fluid phasc concentrations of
1 0 pM prothrombin and cithcr 0 05 nM (O) or 0.50 nM (A) factor Xa at
a flow ratc of 94 pl/min
the absence of phospholipids thrombin generation was not
detectable (Fig. 1). Also when the factor Va perfusion step was
omitted thrombin activity was not measurable. Thus, factor Xa
alone did not produce thrombin at detectable rates whether
phospholipids were present or not.
The Steady-State Rate of Thrombin Formation as Function of the
Amount of Phospholipid-Bound Factor Va
We were intrigued by the stable steady-state rate of thrombin
formation, and we were curious to find out to what extent the
steady-state was a measure for the amount of surface-bound
prothrombinase Thus we varied the amount of factor Va bound,
which was achieved by varying the factor Va concentration of the
perfused solution Subsequently we determined the steady-state
rates of thrombin formation by perfusion of factor Xa and
prothrombin.
The results, shown in Fig.2, demonstrate that the steady-state
rate of thrombin formation increases linearly with the amount of
bound factor Va up to 2.5 fmol factor Valcm2. It is also seen that
the steady-state levels are independent of the fluid phase fac-
tor Xa concentration when it varies from 0.05 to 0.50 nM In this
range of factor Xa concentrations the phospholipid-bound fac-
tor Va can thus be saturated with factor Xa irrespective of the
concentration of the latter. Linear regression analysis of the data
revealed that 1 fmol factor Va/cm2 results jn a steady-state rate of
thrombin formation of 2.0 +^ 0.1 (SE) pmol/min. With an interior
capillary surface of 2.37 cm', thrombin is thus generated with a
rate of 870 + 40 mol/min per mol prothrombinase.
The Influence of the Fluid Phase Factor Xa Concentration and the
Flow Rate on the Rate of Generation of Prothrombinase
Although, the steady-state level of prothrombinase activity is
not influenced by the fluid phase factor Xa concentration, the
formation rate of prothrombinase decreases drastically with
decreasing factor Xa concentrations, which is shown in Fig.3.
In the presence of 0.50 nM factor Xa thrombin generation
starts at about 1 min and reaches the steady-state at approxi-
mately 4 min. In the presence of 0.05 nM factor Xa thrombin
generation starts at roughly the same time, however, it takes
o
A
o
o
oo
-A-6-A-A-4-A-A-A-A
qa
A
I
A
2.5
2.0
1 . 5
1 . 0
0.5
E
E
o
Eo
z
o
I
E
o
l!
z
o
I
o
E,
-
F
E
E
o
E
o
-
o
l-
I
c
o
ll
-
o
t
o
E
E
F
1 . 2
0.0  E
0.02320t 51 0
TIUE (mln)
Flg.3 The effect of factor Xa concentration on the course of the rate of
thrombin formation. Capillaries containing phospholipid-bound factor Va
were perfused with 1.0 pM prothrombin and factor Xa at94 pl/min The
experiments were conducted with 0.50 nM factor Xa and 2.5 fmol factor
Va/cm2 (O) or 0 05 nM factor Xa and 2.6 fmol factor Va/cm2 (A)
about 15 min before the steady-state is reached. At the steady-
state thrombin was generated at an average rate of 5.8 pmol/min
by approximately 6.0 fmol prothrombinase. The first derivatives
of the curves reveal that at the onset of thrombin, its rate of
formation increases with 5.3 pmoUmin per min and 0.60 pmoU
min per min at 0.50 and 0.05 nM factor Xa, respectively. Thus,
after the lag-phase prothrombinase activity is generated at a rate
of 5.5 fmol/min (0.50 nM factor Xa) and 0.62 fmoVmin (0.05 nM
factor Xa).
The rate of formation of prothrombinase is also influenced by
the flow rate. This is seen in Fig.4, where thrombin formation was
studied at a flow rate of 48.4 pl/min (wall shear rate 42 s-r).
Thrombin generation now starts at approximately 2 min and
reaches a steady-state endlevel at 7 min, and the prothrombinase
activitv is generated at a rate of 2.6 fmol/min.
Steady-State Rates of Generation of a-Thrombin and
Meizothrombin (Des Fragment 1) at Varying Prothrombin
Concentrations
When prothrombin activation by prothrombinase is monitored
via amidolytic activity measurements we cannot discriminate a-
thrombin and meizothrombin (des fragment 1) as the products
0.4 0.E
PROTHROUBIN (rn)
Flg. 5 The steady-state rate of thrombin formation as function of the
prothrombin concentration Prothrombin was activated by 0.05 nM
factor Xa in the presence of I 9 fmol factor Va/cm2 at a flow rate of 30 pl/
min Thc amounts of total amidolytic thrombin activity (O), as well as the
amounts of n-thrombin (A) and meizothrombin (des fragment 1) (tr)
formed were determined
formed. It has been shown in static, closed systems that,
depending on the prothrombin concentration, large amounts of
meizothrombin (des fragment 1) are formed during prothrombin
activation by complete prothrombinase (4, 8). Therefore, we
investigated whether the formation of meizothrombin (des frag-
ment 1) also occurs in our continuous flow system.
We assayed the amidolytic thrombin activity determined at the
capillary outlet for the presence of meizothrombin (des frag-
ment 1). This was achieved by taking advantage of the fact that o-
thrombin is rapidly scavenged by AIIII in the presence of
heparin, whereas the inhibition of meizothrombin (des frag-
ment 1) by ATIII is slow and is not enhanced by heparin (8). The
steady-state rates of s-thrombin and meizothrombin (des frag-
ment 1) formation as function of the fluid phase prothrombin
concentration are depicted in Fig.5. Our data show, that up to
0.20 pM prothrombin no significant amounts of meizothrombin
(des fragment 1) are formed; when the prothrombin concentra-
tion increases further up to 1.0 pM the relative amount of
meizothrombin (des fragment 1) formed increases tp to 32"h. In
addition, the steady-state rates of formation of overall thrombin
activity (o-thrombin plus meizothrombin [des fragment 1]) are
linearly dependent on the prothrombin concentration up to
0.50 pM of prothrombin. A deviation from linearity is seen when
the prothrombin concentration increases to 1.0 pM. Thus during
continuous flow the relative rates of formation of o-thrombin and
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Fig 4 Time course of the thrombin generation rate.
Prothrombin (1 0 pfU) and factor Xa (0.50 nM) were per-
fused at a flow rate of 48.4 pl/min through a factor Va
containing phospholipid coated capillary. The amount of
factor Va was 3.3 fmol/cm'
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meizothrombin (des fragment L), as well as the overall rates of
activation of prothrombin are dependent on the fluid phase
prothrombin concentration up to at least 1.0 pM of prothrombin.
Interestingly, we have previously found that, in vesicle type
experiments the rate of prothrombin activation is virtually inde-
pendent of the prothrombin concentration at concentrations of
0.6 pM and higher (8).
Discussion
In this study we investigated the prothrombinase-catalyzed
activation of prothrombin during laminar flow through capillaries,
at 25'C. The capillaries were provided with a phospholipid
bilayer attached to the interior surface, and then perfused with a
factor Va containing solution. The amount of bound factor Va
was determined after washing, and we found that significant
amounts of factor Va were retained. A factor Va influx of
0.15 nM at a flow rate of 30 pl/min for 10 min resulted ln a l2Yo
factor Va binding of 2.4 fmollcm2. It has been reported that
factor Va-binding to phospholipid vesicles, composed a 2025%
phosphatidylserine and 75-80% phosphatidylcholine, is satured at
a phospholipid to protein ratio (mol/mol) varying between 57 and
100 (18, 19). Phospholipid vesicles are highly curved, however,
relative to the molecular dimensions of proteins, the phospholipid
bilayer attached to a capillary can be regarded as a plane. Since
maximum surface concentration (factor V, factor X, prothrom-
bin) seems to be independent of the curvature of the surface (20),
it can be estimated, from the factor Va-binding data (18, 19) and
the amount of phospholipid bound to the capillaries (6.5 x
10-10 moVcm2;, that under the conditions used, less than 0.04o/o
of the maximum factor Va binding capacity was used.
At such a low surface concentration the adsorption of fac-
tor Va is limited by the diffusion-dependent flux of factor Va
towards the surface (20). In which case, according to eq.I, the
adsorption of factor Va in a given time should decrease for
increasing distances from the tube entrance. Thus, the inlet part
of a capillary should contain a significant higher amount of
factor Va as compared to the outlet part. We investigated the
distribution of the bound factor Va by breaking a capillary into
two pieces of equal length The observed distribution was almost
homogeneous (1:0.81). A full explanation for the apparent
deviation from theory is not yet at hand, however, it can be
speculated that the phospholipid-bound factor Va can diffuse
laterally across the surface, as has been described for lipid-bound
antibodies in phospholipid monolayers (21).
Factor Va containing phospholipid-coated capillaries were per-
fused with factor Xa and prothrombin, drops were collected at
the capillary outlet and assayed for thrombin. The thrombin
concentrations determined where multiplied by the flow rates at
which the perfusions with factor Xa and prothrombin were
performed, to obtain overall rates of thrombin generation.
Thrombin generation showed a short lag-phase followed by an
increase ofthe rate ofprothrombin activation, until a steady-state
end-level was reached. The obtained steady-state prothrombinase
activity was stable for a relatively long period of time (20 min in
Fig. 1, 40 min in Fig.4). Because, at the flow rate and prothrom-
bin concentration employed in the experiment depicted in Fig. 1,
the steady-state rate of thrombin generation is direct proportional
to the amount of surface-bound prothrombinase (Fig.2) rhe
stability of the steady-state indicates, that during the perfusion
with factor Xa and prothrombin the prothrombinase is not
washed out. This could be confirmed; after a capillary had been
perfused for 25 min with 0.50 nM factor Xa and 1.0 pM pro-
thrombin at a flow rate of 94 1tllmin, the factor Va surface
concentration was 2.5 fmol/cm2. ln a control experiment the
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amount of factor Va at the onset of the perfusion with factor Xa
and prothrombin was 2.4 fmoUcm'.
Further evidence for a very tight assembly of prothrombinase
was found in the observation that the steady-state prothrombinase
activity was independent of the factor Xa concentration when it
varied L0-fold from 0.05 to 0.50 nM. Apparently the factor Va
bound to the phospholipid surface can be saturated with fac-
tor Xa, even in the presence of the very low fluid phase factor Xa
concentration of 0.05 nM.
It is seen from Figs. 3 and 4 that, under the specific conditions,
it takes considerable time before the steady-state prothrombinase
activity is reached. The time to reach steady-state depends on at
least three phenomena. First of all, the capillary content has to be
replaced by the solution containing factor Xa and prothrombin,
secondly, factor Xa and prothrombin have to be transferred
through the boundary layer to the phospholipid surface, and
thirdly, the thrombin formed has to move from the catalytic sites
into the bulk solution in order to leave the capillary.
The rate of formation of prothrombinase depended on the fluid
phase factor Xa concentration and the flow rate. At a flow rate of
94 pllmin and in the presence of 0.05 M factor Xa the rate of
formation of prothrombinase was 0.62 fmoUmin, with 0.50 nM
factor Xa the rate was 5.5 fmol/min (Fig.3). At a flow rate of
48.4 pl/min, in the presence of 0.50 nM factor Xa the rate of
formation of prothrombinase was 2.6 fmollmin (Fig. a). Because
the prothrombin concentrations were at least 2,000-times in
excess over the factor Xa concentrations, the diffusion limited
rate of transport of prothrombin to the phospholipid surface is at
least 3 orders of magnitude higher than the diffusion limited rate
of transport of factor Xa to the surface. Therefore it is well
feasible that under these conditions, the time delay required to
reach the steady-state prothrombinase activity is dependent on
the flux of factor Xa to the phospholipid-bound factor Va.
According to eqs. I and II (Materials and Methods) the diffusion
controlled transfer of factor Xa to the surface indeed increases
with increasing fluid phase factor Xa concentrations and flow
rates.
We have previously demonstrated, that if factor Xa is present
as part of the fully assembled prothrombinase, a significant
amount of meizothrombin (des fragment 1) is formed (8). The
first step in the formation of this product is the generation of
meizothrombin. Meizothrombin is formed when prothrombin is
specifically cleaved at only one of the factor Xa-cleavage sites
present in prothrombin. This cleavage has as consequence that
the thrombin active site becomes exposed. Meizothrombin is very
rapidly processed further, and gives rise to the formation of
meizothrombin (des fragment 1). Meizothrombin (des frag-
ment 1) is a "dead-end" product, because the protein, lacking the
phospholipid- and Ca2+-binding regions, is not as good a substrate
for the prothrombinase as prothrombin is. Moreover its reactiv-
ity, as compared with thrombin, towards macromolecular sub-
strates, e. g. fibrinogen, antithrombin III, and factor V, is greatly
reduced.
It has been shown in static, closed systems, that the relative
amounts of o-thrombin and meizothrombin (des fragment 1)
formed depend on the prothrombin concentration (4, 8). In
keeping with these findings we observed, that also during
continuous flow, the relative contribution of meizothrombin (des
fragment 1) to the total amidolytic activity increases when the
prothrombin concentration increases. However, in contrast to
previous work (8), where at 1.0 pM prothrombin 84"k of the
product was meizothrombin (des fragment 1), we observed that
during flow the relative amount of meizothrombin (des frag-
ment 1) formed is diminished to 32o/". Apparently, during flow
the major prothrombin activation product is o-thrombin instead
of meizothrombin (des fragment 1).
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